Niva Bupa Health Insurance Company Limited has informed the Exchange regarding Appointment of Ms. Siobhan Djihan Moynihan as Non- Executive Director of the company w.e.f. May 15, 2026.
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Niva Bupa's board meeting on May 8, 2026 approved multiple changes. Two new Non-Executive Directors were appointed — Mr. Christopher Patrick Carroll (CEO of Bupa Global, India & UK) and Ms. Siobhan Djihan Moynihan (CFO of Bupa Global, India & UK) — both effective May 15, 2026, subject to shareholder approval within three months. Simultaneously, two Non-Executive Directors — Ms. Penelope Ruth Dudley and Mr. Carlos Antonio Jaureguizar Ruiz-Jarabo — resigned effective close of business on May 8, 2026, citing insufficient time due to other professional commitments. The Board also elevated Mr. Ankur Kharbanda (Executive Director & CBO) to Executive Director & Deputy CEO, and approved a grant of 12,251,268 ESOPs (exercise price ₹72.45 per option) to eligible employees under the ESOP Scheme 2024.
Two director departures and two new appointments reflect board churn, likely linked to Bupa group restructuring. The Deputy CEO elevation signals internal succession planning. The large ESOP grant aligns management incentives with performance.